Europe TSM (Testing, Screening & Monitoring) Devices Market Outlook, 2031
The Europe TSM (Testing, Screening & Monitoring) Devices Market is segmented By Product (Blood Glucose Monitor, Blood Pressure Monitoring, Pulse Oximeter, Heart Rate Monitors, ECG Devices, Drug Alcohol Screening Testing, Temperature Monitoring, Fetal Monitoring Devices, Multi Parameter Patient Monitoring Device, Others); By Indication (Wound Care, Diabetes, Respiratory Diseases, Cardiovascular Disorders & Hypertension, Cancer, Pregnancy, Hearing Disorders, Other Indications); By End User (Hospitals and Clinics, Home Care, Other End User).
- Bonafide Research
- 22-01-2026
- Pages : 95
- Figures : 9
- Tables : 20
- Region : Europe
- Category : Lifescience & Healthcare
- Medical Devices
Europe TSM market may add over USD 15.03 Billion (2026–2031), driven by strong medtech ecosystem and research-led innovation.
- Historical Period2020-2024
- Base Year2025
- Forecast Period2026-2031
- Largest Market Germany
- Fastest Market Spain
- Format
Featured Companies
- 1. Medline Industries, LP
- 2. Koninklijke Philips N.V.
- 3. Nihon Kohden Corporation
- 4. Cardinal Health, Inc.
- 5. Abbott Laboratories
- 6. Omron Healthcare (Omron Corporation)
- More...
TSM (Testing, Screening & Monitoring) Devices Market Analysis
In the world of testing, screening, and monitoring TSM devices, Europe is a thriving center of innovation and improvement with a healthy industry that is expected to grow rapidly. Europe's TSM sector includes a wide range of sectors that play a part in the region's changing terrain. These industries include pharmaceuticals, healthcare, biotechnology, environmental sciences, and more. Throughout Europe, the proliferation of TSM devices is still mostly driven by the healthcare industry. Smart testing, screening, and monitoring devices are in high demand due to an aging population and a growing emphasis on preventative healthcare measures. Thanks to this trend, significant funds have been allocated to research and development, which has accelerated technological progress and resulted in the release of state-of-the-art TSM devices. Several European nations, including the UK, France, Germany, and Switzerland, have become major players in the TSM device business. These countries have robust R&D, manufacturing, and research infrastructures that support the creation of innovative technology. Furthermore, the European biotechnology and pharmaceutical industries have made a substantial contribution to the market growth for TSM devices. The demand for specialized testing and screening devices has increased due to the necessity for strict quality control measures, effective drug development procedures, and precise monitoring systems. Advanced TSM technologies are being used as a result of regulatory criteria that emphasize product efficacy and safety, further fueling this need. The European TSM devices market is characterized by a diverse range of products catering to various industries and applications. Innovative technologies such as molecular diagnostics, point-of-care testing devices, biosensors, and wearable monitoring systems are gaining prominence, offering accurate and rapid results while ensuring convenience and ease of use. According to the research report, " Europe TSM Market Outlook, 2031," published by Bonafide Research, the Europe TSM market is anticipated to add to more than USD 15.03 Billion by 2026-31. Europe has a thriving and diverse medical technology ecosystem, with top businesses and research centers dispersed around the region. Europe creates an ecosystem that is dynamic for creating and commercializing modern testing devices, from larger, more established company such as Siemens Healthineers to smaller and more agile startups. In fields like point-of-care diagnostics, remote patient monitoring, and personalized medicine, this collaborative culture promotes idea sharing and quick progress. Europe understands how testing and monitoring may be revolutionized by using data and artificial intelligence. A secure and interoperable platform for exchanging medical data is what projects like the European Health Data Space want to establish in order to facilitate quicker diagnosis, more individualized treatment regimens, and better patient outcomes. , businesses and academic organizations are working hard to create AI-powered algorithms for evaluating medical photos and data, leading to earlier detection of diseases and more accurate diagnoses. Countries like Germany, renowned for its engineering prowess, have led the charge in producing high-quality medical devices. The United Kingdom's healthcare system has driven innovation in remote monitoring technologies, while France's focus on research and development has yielded breakthroughs in diagnostic imaging devices. Switzerland, with its strong pharmaceutical industry, has been a nucleus for the development of precision monitoring tools and biosensors.
to Download this information in a PDF
What's Inside a Bonafide Research`s industry report?
A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.
Download SampleMarket Dynamic
Market Drivers • Aging Population & Preventive Care Emphasis: Europe sees a swiftly growing elderly demographic with a corresponding rise in chronic health issues. This scenario heightens the demand for devices that allow for continuous monitoring. Governments advocate for preventive healthcare to minimize treatment expenses. There is a strong push for early screening initiatives. Older individuals are increasingly depending on ongoing monitoring technologies. The significance of home-based testing is on the rise. These elements significantly enhance market growth. • Strong R&D and Manufacturing Base: Europe is home to prominent manufacturers of medical devices and research organizations. Nations such as Germany, France, and the UK allocate substantial funds towards healthcare advancements. Robust teamwork between universities and industries aids in the creation of devices. Elevated production criteria enhance the quality of products. Government funding promotes research efforts. A focus on exports boosts market visibility. This foundation promotes consistent market growth. Market Challenges • Strict and Changing Regulations MDR/IVDR : The Medical Device Regulation and IVDR in the EU mandate rigorous compliance standards. The processes for obtaining approval are long and expensive. Regular updates to regulations add confusion for producers. Smaller businesses find certification expenses difficult. A shortage of notified bodies leads to delays in approvals. Adhering to regulations can postpone the launch of products. This can hinder innovation and market introduction. • Diverse Healthcare Systems: Healthcare systems across Europe differ from one nation to another. Policies for reimbursement vary widely from region to region. Strategies for entering the market must be tailored to each country. This increases the complexity of operations. Rates of adoption differ depending on national funding. Coordinating across various systems is difficult. This fragmentation hinders uniform market growth. Market Trends • Rise of Wearable and Home Monitoring Devices: The need for wearable monitoring gadgets is growing steadily. Patients show a preference for solutions that allow them to test and monitor their health at home. Wearable devices aid in the management of chronic illnesses. They enhance patient involvement and adherence to treatment. An aging demographic boosts the use of home monitoring products. These devices help reduce the strain on healthcare facilities. This trend promotes a shift towards decentralized healthcare. • Collaborations and Tailored Care Solutions: There is an increase in partnerships between technology firms and healthcare providers. Such alliances support customized monitoring solutions. Car driven by data leads to better results for patients. Combined platforms offer diagnostics, monitoring, and analytics. Governments back innovative collaborations. Personalized medicine is gaining widespread acceptance. This trend increases long-term market value.
TSM (Testing, Screening & Monitoring) Devices Segmentation
| By Product | Blood Glucose Monitor | |
| Blood Pressure Monitoring | ||
| Pulse Oximeter | ||
| Heart Rate Monitors | ||
| ECG Devices | ||
| Drug Alcohol Screening Testing | ||
| Temperature Monitoring | ||
| Fetal Monitoring Devices | ||
| Multi Parameter Patient Monitoring Device | ||
| Others | ||
| By Indication | Wound Care | |
| Diabetes | ||
| Respiratory Diseases | ||
| Cardiovascular Disorders & Hypertension | ||
| Cancer | ||
| Pregnancy | ||
| Hearing Disorders | ||
| Other Indications (sleep disorders, Movement Disorders, kidney disorders, neurovascular diseases, and HIV) | ||
| By End user | Hospitals and Clinics | |
| Home care | ||
| Other End User | ||
| Europe | Germany | |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Russia | ||
The others product category in Europe maintains the largest market share owing to significant demand for laboratory services, confirmatory testing, and compliance-oriented screening solutions. The others product category in Europe comprises the biggest portion of the Total Screening Market as European stakeholders emphasize thorough and service-oriented screening methods. This category encompasses laboratory testing services, confirmatory examinations, reagents, software solutions, and tailored screening offerings that go beyond typical rapid testing devices. European regulations stress the importance of precision, traceability, and multi-step validation, increasing dependency on these sophisticated options. Europe’s regulatory framework mandates comprehensive documentation and confirmatory testing for workplace safety, transportation, and public health screening initiatives. Initial screening outcomes often need to be confirmed through laboratory evaluations, reallocating a significant portion of market value toward service-oriented and analytical solutions classified as Others. Nations including Germany, the United Kingdom, France, and the Netherlands possess developed laboratory infrastructures that facilitate extensive confirmatory testing. The others category is further enhanced due to strict regulations on data protection and privacy, such as GDPR. These regulations lead to a growing need for secure data management systems, compliant reporting tools, and outsourced screening services that ensure adherence to the law. Numerous organizations in Europe favor using external providers for these functions, which results in consolidated expenditures within this category. Europe’s focus on research, harm reduction, and public health surveillance fosters the use of advanced analytical methods like chromatography and mass spectrometry. These technologies are often offered as part of specialized services instead of individual products. Consequently, the extensive reach, regulatory significance, and high-value aspect of these solutions render the others product category the primary contributor to the Europe TSM market. Cardiovascular disorders and hypertension are the leading segment in Europe’s TSM market, driven by the aging population and the substantial impact of heart-related illnesses that require ongoing screening and extended monitoring. Cardiovascular diseases and high blood pressure make up the largest part of the Testing, Screening & Monitoring TSM devices market in Europe, primarily due to the fact that these diseases are the top cause of death in the region. With Europe having a notably aging demographic, age serves as a significant risk factor for heart issues, hypertension, and associated complications. Consequently, a substantial segment of the population needs regular monitoring of blood pressure, cardiac evaluations, and ongoing health assessments. European healthcare systems strongly focus on early identification, prevention, and managing long-term health issues, leading to a steady need for devices related to cardiovascular screening and monitoring. Many public health initiatives in various European countries encourage routine blood pressure screenings and evaluations of heart health, which enhances their acceptance. Moreover, high blood pressure is often a silent illness that needs ongoing monitoring instead of just one test, thereby boosting the utilization of monitoring devices. Europe has clear clinical guidelines that require regular cardiovascular evaluations for groups at high risk, such as older individuals and those suffering from diabetes or obesity. Innovations in technology, including portable blood pressure monitors, wearable ECG devices, and home cardiac monitoring systems, have become a common part of standard care. , government-funded healthcare systems throughout Europe facilitate greater access to cardiovascular monitoring devices, resulting in their use being more widespread compared to other health conditions. The chronic and long-lasting nature of cardiovascular diseases, paired with their high prevalence and effective preventive healthcare strategies, reinforces the status of cardiovascular diseases and high blood pressure as the leading segment of the European TSM market. In Europe, the Home-care end-user segment is experiencing rapid growth due to an aging population, a shift towards decentralized healthcare, and an increasing preference for screening solutions at home. In Europe, the Home-care end-user segment is the fastest expanding area within the Total Screening Market, as healthcare systems progressively transition from hospital-based approaches to community and home care models. Countries in Europe are dealing with quickly aging populations, creating a greater need for ongoing monitoring and routine screening outside conventional healthcare facilities. Home-care screening options facilitate early disease detection, management, and continuous monitoring while alleviating pressure on hospitals. Europe’s public healthcare systems actively support affordable care models, advocating for patients to handle chronic health issues and preventive screenings in their homes whenever feasible. Home-based assessments correspond with national healthcare goals aimed at decreasing hospital admissions, reducing the length of hospital stays, and maximizing resource use. Consequently, governments and healthcare organizations are increasingly backing the reimbursement and use of home-care screening solutions. The Home-care segment enjoys a high level of acceptance among patients due to its convenience, privacy, and simplicity. Screening at home reduces the need for travel, cuts down on waiting periods, and lowers the risk of exposure to healthcare settings, which is especially crucial for older individuals and those with mobility challenges. The growth in easy-to-use, portable, and digitally linked screening tools has sped up their use in households across Europe. Moreover, Europe's focus on preventive healthcare and early detection encourages regular self-testing and home monitoring. The incorporation of digital health platforms means that test results can be safely shared with healthcare providers, ensuring clinical supervision while giving patients more control. Regulatory backing for decentralized testing and telemedicine enhances this movement.
to Download this information in a PDF
TSM (Testing, Screening & Monitoring) Devices Market Regional Insights
Germany is at the top of the European TSM market thanks to its sophisticated medical production skills, strong engineering knowledge, and central position in Europe’s healthcare technology supply chain. Germany occupies a top spot in the market for Testing, Screening, and Monitoring TSM devices in Europe largely due to its robust industrial sector and extensive experience in medical engineering and production. The nation is identified as the foremost producer and exporter of medical devices in Europe, providing high-caliber diagnostic and monitoring tools throughout the region. Manufacturers in Germany are esteemed for their precise engineering, dependability, and adherence to strict European quality regulations, thereby fostering confidence and acceptance in healthcare systems. The country also enjoys a well-structured healthcare framework that effectively incorporates cutting-edge medical technologies in clinical settings. German hospitals and diagnostic facilities often act as early implementers and testing grounds for new TSM devices. Strong partnerships among research bodies, educational institutions, and medical tech firms drive ongoing innovation. Support from the government for healthcare digitization and medical research further solidifies its leading market position. Germany's central geographic location in Europe, along with its advanced logistics and distribution systems, facilitates effective supply of TSM devices across EU markets. Moreover, Germany significantly influences the development of European regulatory standards, enabling local manufacturers to respond swiftly to regulations such as MDR and IVDR. The focus on quality production, export capabilities, and the merging of engineering excellence with healthcare demands solidifies Germany's dominant role. These industrial and structural strengths align to position Germany as the foremost country in the TSM market of Europe.
to Download this information in a PDF
Companies Mentioned
- Medline Industries, LP
- Koninklijke Philips N.V.
- Nihon Kohden Corporation
- Cardinal Health, Inc.
- Abbott Laboratories
- Omron Healthcare (Omron Corporation)
- Medtronic plc
- Microlife Corporation
- Mindray Medical International Limited
- Baxter International Inc.
- Siemens Healthineers
Table of Contents
- 1. Executive Summary
- 2. Market Dynamics
- 2.1. Market Drivers & Opportunities
- 2.2. Market Restraints & Challenges
- 2.3. Market Trends
- 2.4. Supply chain Analysis
- 2.5. Policy & Regulatory Framework
- 2.6. Industry Experts Views
- 3. Research Methodology
- 3.1. Secondary Research
- 3.2. Primary Data Collection
- 3.3. Market Formation & Validation
- 3.4. Report Writing, Quality Check & Delivery
- 4. Market Structure
- 4.1. Market Considerate
- 4.2. Assumptions
- 4.3. Limitations
- 4.4. Abbreviations
- 4.5. Sources
- 4.6. Definitions
- 5. Economic /Demographic Snapshot
- 6. Europe TSM (Testing, Screening & Monitoring) Devices Market Outlook
- 6.1. Market Size By Value
- 6.2. Market Share By Country
- 6.3. Market Size and Forecast, By Product
- 6.4. Market Size and Forecast, By Indication
- 6.5. Market Size and Forecast, By End user
- 6.6. Germany TSM (Testing, Screening & Monitoring) Devices Market Outlook
- 6.6.1. Market Size by Value
- 6.6.2. Market Size and Forecast By Product
- 6.6.3. Market Size and Forecast By End user
- 6.7. United Kingdom (UK) TSM (Testing, Screening & Monitoring) Devices Market Outlook
- 6.7.1. Market Size by Value
- 6.7.2. Market Size and Forecast By Product
- 6.7.3. Market Size and Forecast By End user
- 6.8. France TSM (Testing, Screening & Monitoring) Devices Market Outlook
- 6.8.1. Market Size by Value
- 6.8.2. Market Size and Forecast By Product
- 6.8.3. Market Size and Forecast By End user
- 6.9. Italy TSM (Testing, Screening & Monitoring) Devices Market Outlook
- 6.9.1. Market Size by Value
- 6.9.2. Market Size and Forecast By Product
- 6.9.3. Market Size and Forecast By End user
- 6.10. Spain TSM (Testing, Screening & Monitoring) Devices Market Outlook
- 6.10.1. Market Size by Value
- 6.10.2. Market Size and Forecast By Product
- 6.10.3. Market Size and Forecast By End user
- 6.11. Russia TSM (Testing, Screening & Monitoring) Devices Market Outlook
- 6.11.1. Market Size by Value
- 6.11.2. Market Size and Forecast By Product
- 6.11.3. Market Size and Forecast By End user
- 7. Competitive Landscape
- 7.1. Competitive Dashboard
- 7.2. Business Strategies Adopted by Key Players
- 7.3. Porter's Five Forces
- 7.4. Company Profile
- 7.4.1. Abbott Laboratories
- 7.4.1.1. Company Snapshot
- 7.4.1.2. Company Overview
- 7.4.1.3. Financial Highlights
- 7.4.1.4. Geographic Insights
- 7.4.1.5. Business Segment & Performance
- 7.4.1.6. Product Portfolio
- 7.4.1.7. Key Executives
- 7.4.1.8. Strategic Moves & Developments
- 7.4.2. Koninklijke Philips N.V.
- 7.4.3. Nihon Kohden Corporation
- 7.4.4. Siemens Healthineers
- 7.4.5. Mindray Bio-Medical Electronics Co., Ltd.
- 7.4.6. Medline Inc.
- 7.4.7. Baxter International Inc.
- 7.4.8. GE HealthCare Technologies, Inc.
- 7.4.9. Cardinal Health, Inc
- 7.4.10. Medtronic plc
- 7.4.11. Omron Corporation
- 7.4.12. Fukuda Denshi Co., Ltd.
- 8. Strategic Recommendations
- 9. Annexure
- 9.1. FAQ`s
- 9.2. Notes
- 10. Disclaimer
Table 2: Top 10 Counties Economic Snapshot 2024
Table 3: Economic Snapshot of Other Prominent Countries 2022
Table 4: Average Exchange Rates for Converting Foreign Currencies into U.S. Dollars
Table 5: Europe TSM (Testing, Screening & Monitoring) Devices Market Size and Forecast, By Product (2020 to 2031F) (In USD Billion)
Table 6: Europe TSM (Testing, Screening & Monitoring) Devices Market Size and Forecast, By Indication (2020 to 2031F) (In USD Billion)
Table 7: Europe TSM (Testing, Screening & Monitoring) Devices Market Size and Forecast, By End user (2020 to 2031F) (In USD Billion)
Table 8: Germany TSM (Testing, Screening & Monitoring) Devices Market Size and Forecast By Product (2020 to 2031F) (In USD Billion)
Table 9: Germany TSM (Testing, Screening & Monitoring) Devices Market Size and Forecast By End user (2020 to 2031F) (In USD Billion)
Table 10: United Kingdom (UK) TSM (Testing, Screening & Monitoring) Devices Market Size and Forecast By Product (2020 to 2031F) (In USD Billion)
Table 11: United Kingdom (UK) TSM (Testing, Screening & Monitoring) Devices Market Size and Forecast By End user (2020 to 2031F) (In USD Billion)
Table 12: France TSM (Testing, Screening & Monitoring) Devices Market Size and Forecast By Product (2020 to 2031F) (In USD Billion)
Table 13: France TSM (Testing, Screening & Monitoring) Devices Market Size and Forecast By End user (2020 to 2031F) (In USD Billion)
Table 14: Italy TSM (Testing, Screening & Monitoring) Devices Market Size and Forecast By Product (2020 to 2031F) (In USD Billion)
Table 15: Italy TSM (Testing, Screening & Monitoring) Devices Market Size and Forecast By End user (2020 to 2031F) (In USD Billion)
Table 16: Spain TSM (Testing, Screening & Monitoring) Devices Market Size and Forecast By Product (2020 to 2031F) (In USD Billion)
Table 17: Spain TSM (Testing, Screening & Monitoring) Devices Market Size and Forecast By End user (2020 to 2031F) (In USD Billion)
Table 18: Russia TSM (Testing, Screening & Monitoring) Devices Market Size and Forecast By Product (2020 to 2031F) (In USD Billion)
Table 19: Russia TSM (Testing, Screening & Monitoring) Devices Market Size and Forecast By End user (2020 to 2031F) (In USD Billion)
Table 20: Competitive Dashboard of top 5 players, 2025
Figure 2: Europe TSM (Testing, Screening & Monitoring) Devices Market Share By Country (2025)
Figure 3: Germany TSM (Testing, Screening & Monitoring) Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 4: United Kingdom (UK) TSM (Testing, Screening & Monitoring) Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 5: France TSM (Testing, Screening & Monitoring) Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 6: Italy TSM (Testing, Screening & Monitoring) Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 7: Spain TSM (Testing, Screening & Monitoring) Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 8: Russia TSM (Testing, Screening & Monitoring) Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 9: Porter's Five Forces of Global TSM (Testing, Screening & Monitoring) Devices Market
TSM (Testing, Screening & Monitoring) Devices Market Research FAQs
Related Reports
One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. License information
One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. License information
Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. License information
All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). License information
Safe and Secure SSL Encrypted
Quick Contacts
Want to customize this report?
We offer 10% Free Customization at the time of purchase
Get Free Customization
Trusted Partners
Budget constraints? Get in touch with us for special pricing
Request DiscountOrder Detail
- Order Placed (04 May, 2026)
- Notify To Team (04 May, 2026)
- Report updation (05 May, 2026)
- Report Quality Check (05 May, 2026)
- Report Dispatch (06 May, 2026)
- Hard Copy
Recently Viewed Products
Europe TSM (Testing, Screening & Monitoring) Devices Market Outlook, 2031
We are friendly and approachable, give us a call.